Featured Research

from universities, journals, and other organizations

Multiple malaria vaccine offers protection to people most at risk

Date:
October 27, 2011
Source:
University of Edinburgh
Summary:
A new malaria vaccine could be the first to tackle different forms of the disease and help those most vulnerable to infection, a study suggests.

A new malaria vaccine has been created to target different forms of the disease and help those most at risk.

The parasites that cause malaria come in many different forms. This new vaccine works by triggering a range of antibodies to fight the different malaria parasites.

Many existing vaccines target only a limited part of the parasite population, making them less effective.

Combined protection

Scientists at the University created the vaccine by combining multiple types of a key protein found in many different parasite types.

During infection the production of antibodies is triggered by this protein. Mixing multiple proteins induces antibodies against a wide range of malaria parasites.

Tests have shown that antibodies targeting this key protein offer improved protection against the disease. It has also been shown to be effective in animals.

Helping those at risk

Owing to the many different types of parasites, the only way to gain natural immunity to all these forms is to catch multiple strains of the illness.

A vaccine that overcomes this would be most useful to children and other vulnerable populations.

"Our approach is novel because it combines multiple antibody targets from different parasite types, giving broader protection. This could prove to be a useful vaccine," said the study's corresponding author, Dr. David Cavanagh of the University of Edinburgh's School of Biological Sciences.

Widespread infection

Malaria is spread by mosquito bites and affects people and animals. According to the World Health Organisation the disease affected 225 million people in 2009 and caused an estimated 781 000 deaths. Those affected were mostly children in sub-Saharan Africa.

The study, published by PLoS ONE, was supported by the European Commission.


Story Source:

The above story is based on materials provided by University of Edinburgh. Note: Materials may be edited for content and length.


Journal Reference:

  1. Graeme J. M. Cowan, Alison M. Creasey, Kelwalin Dhansarnsombut, Alan W. Thomas, Edmond J. Remarque, David R. Cavanagh. A Malaria Vaccine Based on the Polymorphic Block 2 Region of MSP-1 that Elicits a Broad Serotype-Spanning Immune Response. PLoS ONE, 2011; 6 (10): e26616 DOI: 10.1371/journal.pone.0026616

Cite This Page:

University of Edinburgh. "Multiple malaria vaccine offers protection to people most at risk." ScienceDaily. ScienceDaily, 27 October 2011. <www.sciencedaily.com/releases/2011/10/111026175331.htm>.
University of Edinburgh. (2011, October 27). Multiple malaria vaccine offers protection to people most at risk. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2011/10/111026175331.htm
University of Edinburgh. "Multiple malaria vaccine offers protection to people most at risk." ScienceDaily. www.sciencedaily.com/releases/2011/10/111026175331.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins